Acarix AB (publ) (STO:ACARIX)
Sweden
· Delayed Price · Currency is SEK 0.264
-0.011 (-3.83%)
Mar 9, 2026, 5:29 PM CET
Acarix AB Revenue
In the year 2025, Acarix AB had annual revenue of 7.36M SEK with 18.69% growth. Acarix AB had revenue of 2.14M in the quarter ending December 31, 2025, with 26.02% growth.
Revenue
7.36M
Revenue Growth
+18.69%
P/S Ratio
41.77
Revenue / Employee
920.13K
Employees
8
Market Cap
307.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.36M | 1.16M | 18.69% |
| Dec 31, 2024 | 6.20M | -39.00K | -0.62% |
| Dec 31, 2023 | 6.24M | 419.00K | 7.20% |
| Dec 31, 2022 | 5.82M | 2.06M | 54.84% |
| Dec 31, 2021 | 3.76M | 1.59M | 73.27% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ortoma AB | 67.27M |
| Mentice AB | 284.59M |
| Promimic AB | 51.06M |
| Q-linea AB | 19.46M |
| BrainCool AB | 38.69M |
| Integrum AB | 98.18M |
| Bactiguard Holding AB | 225.57M |
| Clinical Laserthermia Systems AB | 17.49M |